ELAN vs VTRS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ELAN · Elanco Animal Health$25.74 ▲ 8.70%
VTRS · Viatris$19.91 ▲ 4.96%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ELAN +15.6%
- VTRS +102.6%
Head to head
| Metric | ELAN | VTRS |
|---|---|---|
| Price | $25.74 | $19.91 |
| Change today | ▲ 8.70% | ▲ 4.96% |
| Market cap | $12.86B | $22.83B |
| Return, 3 months | +15.5% | +23.2% |
| Return, year to date | +13.7% | +63.6% |
| Return, 1 year | +19.8% | +103.6% |
| P/E (TTM) | – | – |
| P/B | 2.0 | 1.7 |
| P/E percentile vs own 5y | 11th | 15th |
| Dividend yield | – | 2.41% |
| Revenue growth (YoY, latest qtr) | +10.2% | -0.3% |
| Net profit growth (YoY) | +390.9% | -153.7% |
| Gross margin | 55.4% | 35.3% |
| Operating margin | 6.6% | 1.0% |
| Net margin | -4.0% | -4.1% |
| Return on equity | -3.0% | -4.2% |
| Analyst target vs. price | +20.1% | +8.0% |
| Analyst buy share | 86% | 63% |
| RSI (14) | 65 | 68 |
| 30-day volatility | 42.3% | 30.3% |
| Max drawdown, 1 year | -26.2% | -19.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VTRS is the largest of the group by market value.
- VTRS has returned the most over the past year.
- ELAN is growing revenue fastest.
- ELAN keeps the most profit per dollar of sales.
- VTRS has been the calmest stock over the last 30 days.